MedPath

Exercise Dose-response and Protein Requirements

Not Applicable
Completed
Conditions
Exercise Training
Interventions
Other: Endurance exercise
Registration Number
NCT06138951
Lead Sponsor
University of Toronto
Brief Summary

Study will investigate the impact of training volume on protein metabolism to estimate the impact on daily protein requirements of endurance athletes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
7
Inclusion Criteria

Healthy, male, endurance-trained participants who regularly run more than 40 km/week or perform endurance exercise for more than 4.5 hours/week

  • Participants who have a self-reported 5-km run time of ≤23 min
  • Participants who are categorized as at least "very good" based on a study by Shvartz & Reibold (Aviat Space Environ Med. 1990 Jan;61(1):3-11), in which VO2peak is used as an index. (i.e. the participants whose VO2peak is ≥57 ml/kg/min (18-24 y), ≥54 ml/kg/min (25-29 y), ≥52 ml/kg/min (30-34 y), ≥49 ml/kg/min (35-39 y)
  • Ability to complete the 16-km familiarization run on Session 2
  • Aged 18-40 years old
Read More
Exclusion Criteria
    • Inability to meet health and physical activity guidelines according to the PAR-Q+.
  • Female: hormonal fluctuations associated with the menstrual cycle have been reported to alter protein metabolism during exercise and may influence specific amino acid requirements at rest; as such, the present study will test the effect of endurance exercise on protein requirements in males only to ensure a stable hormonal environment and to increase the homogeneity of the physiological response. (NOTE: we plan to test females in a future trial based off of the results obtained herein)
  • Inability to adhere to any of the protocol guidelines (i.e. alcohol, caffeine consumption)
  • Regular tobacco use
  • Illicit drug use (e.g. growth hormone, testosterone, etc.)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Nonexercised rested dayEndurance exerciseAthlete will not exercise on trial day.
Recovery from 10KM runEndurance exerciseAthlete will run 10km on trial day.
Recovery from 20KM runEndurance exerciseAthlete will run 20km on trial day.
Primary Outcome Measures
NameTimeMethod
Phenylalanine excretion8 hours

Excretion of 13CO2 in the breath will be used to estimate the impact of exercise on daily protein requirements. This outcome will include the enrichment of 13CO2 in exhaled breath after the ingestion of \[13C\]phenylalanine tracer and the production of CO2 determined by indirect calorimetry at rest or after exercise.

Secondary Outcome Measures
NameTimeMethod
Phenylalanine flux8 hours

The enrichment of \[13C\]phenylalanine in the urine will be used to estimate the flux of phenylalanine in the body at rest or after exercise.

Phenylalanine oxidation8 hours

The oxidation of \[13C\]phenylalanine will be determined by correcting phenylalanine excretion by phenylalanine flux.

Trial Locations

Locations (1)

Goldring Centre for High Performance Sport at the University of Toronto

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath